Masimo
MASI
#2479
Rank
NZ$12.22 B
Marketcap
NZ$227.54
Share price
-0.89%
Change (1 day)
-26.38%
Change (1 year)
Masimo is an American manufacturer of noninvasive patient monitoring technologies based in Irvine, California.

P/E ratio for Masimo (MASI)

P/E ratio as of February 2026 (TTM): -13.1

According to Masimo's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -13.0585. At the end of 2024 the company had a P/E ratio of -29.1.

P/E ratio history for Masimo from 2007 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-29.1-138.24%
202376.1
202170.415.39%
202061.042.01%
201943.047.61%
201829.1-11.13%
201732.7193.41%
201611.2-56.18%
201525.5
201328.4

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Thermo Fisher Scientific
TMO
33.6-356.93%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
40.8-412.71%๐Ÿ‡บ๐Ÿ‡ธ USA
ResMed
RMD
26.0-298.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
32.9-351.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Forest Products
UFPI
19.4-248.49%๐Ÿ‡บ๐Ÿ‡ธ USA
CONMED
CNMD
19.0-245.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
-0.1609-98.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Philips
PHG
126-1,063.95%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.